US Patent 12016893 Oncolytic viruses for modified MHC expression
Patent 12016893 was granted and assigned to KalIvir Immunotherapeutics on June, 2024 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
December 13, 2022
0
Date of Patent
June 25, 2024
0
Patent Applicant
Patent Application Number
18080253
0
Patent Citations
•••
Patent Inventor Names
Stephen Howard Thorne
0
Mingrui Zhang
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 12016893 Oncolytic viruses for modified MHC expression
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
